Systemic Drug Treatment in Dermatology

Systemic Drug Treatment in Dermatology : A Handbook

Edited by Sarah H. Wakelin , Edited by Howard I. Maibach , Edited by Clive B. Archer , Edited by Clive Archer , Contributions by Daniel Creamer , Contributions by W. J. Cunliffe , Contributions by J. Barker , Contributions by M. M. Black , Contributions by A. Evans , Contributions by C. Gooptu

List price: US$57.03

Currently unavailable

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

There has been an increase in the use of systemic drug therapy for skin diseases during recent years. This reflects advances in drug development but many are potent drugs which can have serious or life threatening adverse effects. Aimed at dermatologists and general practitioners, this book provides an accessible and concise aid to prescribing and monitoring systemic dermatological therapy. Evidence based data or established guidelines have been included where possible. Common and important adverse drug effects and their management are covered along with some of the recent advances in drug treatment and monitoring of patients.

show more
  • Paperback | 256 pages
  • 132 x 186 x 14mm | 399.17g
  • 01 Jun 2002
  • Manson Publishing Ltd
  • London
  • English
  • 9 charts, 16 tables
  • 1840760133
  • 9781840760132
  • 1,521,260

Other books in this category

Other people who viewed this bought:

Review quote

...a useful resource... definitely one to have somewhere near the clinic. -Dermatology in Practice Contains a huge amount of relevant and easily retrievable clinical information...well worth buying. -Update essential addition for anyone interested in practising dermatology safely. -Primary Care Dermatology Society Bulletin For those training in dermatology this is a book you must read. -British Journal of Dermatology

show more

Back cover copy

The author provides a concise aid to prescribing and monitoring systemic drug therapy in skin diseases, for dermatologists and general practitioners, including common or important adverse drug effects, using evidence-based data or established guidelines, and covering recent advances.

show more